Medicines as an investment, not a cost, for the NHS

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.643, 2011-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UK NHS told to spend more on medicines

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 246, 2000-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Cost sharing suggested for UK NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 296, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Preventable adverse events cost UK NHS dearly

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 303, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Is the high cost of patented medicines and hormones being overcome?

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 305-305

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Acupuncture for chronic headache worth the extra cost to the UK NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite